June 5, 2018 — The future of cardiovascular care will be transformed by advances in artificial intelligence, digital...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
Digital mHealth advances like wearable heart monitors, smartphone apps and artificial intelligence will reshape the standard of care in the coming years according to three recent JACC articles.
Feature | Information Technology | June 05, 2018
A severe radiation burn caused by extended X-ray angiography in the same location during an interventional procedure in the cath lab. Controlling cath lab radiation dose was a big topic this past month, with three articles on this subject making the top 20 list. This image is a figure included in the new joint cardiology society consensus document on radiation from medical imaging from the third story on this list.
Feature | June 01, 2018 | Dave Fornell, Editor
June 1, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
Figure 1: Images showing the effect of both surgical epicardial PEF ablation and catheter based PEF ablation in the first-in-human electroporation ablation study to freat Afib.
News | May 25, 2018
May 25, 2018 — Data from the first-in-human study using pulsed electric field (PEF) energy ablate heart tissue in...
Image courtesy of Intermountain Medical Center Heart Institute
News | Atrial Fibrillation | May 24, 2018
May 24, 2018 — Atrial...
New cardiac monitoring technologies allow for longer duration data collection. The Medtronic Reveal Linq implantable cardiac monitor allows for 24/7 monitoring for up to three years. This might not be necessary for most patients, and there are several newer Holter monitors that can record up to several days or several weeks of data in real-time.
Blog | ECG Wireless Remote Access | May 23, 2018
New patient monitoring technologies with wireless connectivity have enabled a revolution in cardiac event and...
News | Cardiac Resynchronization Therapy Devices (CRT) | May 22, 2018
May 22, 2018 — Medtronic plc announced...
News | Ablation Systems | May 22, 2018
May 22, 2018 — LuxCath LLC showcased the next generation of its proprietary OmniView light-guided...
The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.
News | Ablation Systems | May 21, 2018
May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-...
The Abbott Advisor HD mapping catheter and the Biosense Webster Vizigo introducer were among two of the top innovations displayed on the show floor of Heart Rhythm 2018.
Blog | HRS | May 21, 2018
Electrophysiology is one of the most rapidly-growing areas of healthcare. That may be why it’s the focus of so many...
A slide image from Reddy's presntation at Heart Rhythm 2018, showing thrombus formation on the face of a Watchman device in an echo image.
Feature | Left Atrial Appendage (LAA) Occluders | May 18, 2018
May 18, 2018 — Left atrial appendage closure (LAAC) with the transcatheter Watchman device prevents thromboembolism...
News | Antiplatelet and Anticoagulation Therapies | May 18, 2018
May 18, 2018 — Nearly half of patients prescribed warfarin and just under one third of those using newer direct oral...
Figure 1: At the end of 36 months, the incidence of any atrial tachyarrhythmia was 23.3 percent in the botox group, as compared to 50 percent in the placebo group
News | Atrial Fibrillation | May 18, 2018
May 18, 2018 — Three year results of a study found injection of botulinum toxin into epicardial fat pads in...
A live EP case presentation during the 2018 Heart Rhythm meeting.
Feature | HRS | May 18, 2018 | Dave Fornell
Here is an aggregation of all the news and late-breaking studies presented at the 2018...
